EVOKE PHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
EVOKE PHARMA, INC. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $164.47 per share as of 2024-11-30, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2025-03-13
- 2024-11-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $164.47.
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.19.
- 2014-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.67.
- 2013-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $7.61.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2024-11-30 | $164.47 10-K · filed 2025-03-13 |
| 2015-12-31 | $7.19 10-K · filed 2016-03-10 |
| 2014-12-31 | $7.67 10-K · filed 2016-03-10 |
| 2013-12-31 | $7.61 10-K · filed 2015-03-04 |
| 2012-12-31 | $0.40 10-K · filed 2014-03-25 |